Our news
Ventio at the “Workshop BioImaging and the EOSC” at Heidelberg in Germany – focus on the FAIRification of imaging data
Ventio at the “Workshop BioImaging and the EOSC” at Heidelberg in Germany – focus …
Ventio at the 2023 SFRMBM Congress
Ventio at the 2023 SFRMBM Congress Sponsor of the 2023 congress of the SFRMBM (Société Française de …
How and why should software testing be implemented ?
How and why should software testing be implemented? Davy becomes ISTQB expert In Decembe…
Ventio joins Medicen for the development of innovative health technologies
Ventio joins Medicen for the development of innovative health technologies. Medicen is 120 companies…
SFRMBM 2023
Ahead : We are sponsor of the 2023 congress of the French Society of Magnetic Resonance and Medical …
QSM Quantitative Susceptibility Mapping
Dr. Stephane ROCHE, PhD, Dr. Ludovic de ROCHEFORT, PhD; Novembre 2022 Definition: QSM (Quantitative …
Medical Imaging Innovation Award
Ventio receives the Medical Imaging Innovation Award (JFR, Paris, 2022) The 70th edition of the Jour…
QMR Lucca workshop on QSM and MRI
QMR Joint Workshop on MR phase, magnetic susceptibility and electrical properties mapping Lucca (Ita…
World Alzheimer’s Day 2022
Ventio participates to the follow-up of Alzheimer’s disease patients by offering a patented, i…
Jacques Badagbon’s new professional skills on ISO27001 implementation
Jacques Badagbon’s new professional skills on ISO27001 implementation Last May, Jacques had su…
Ventio – innovation in digital health
Indeed, the company has been hosted by Marseille Innovation for one year and has benefited from the …
Davy Cam becomes a Certified Tester – ISTQB Foundation
Davy Cam becomes a Certified Tester – ISTQB Foundation In June 2022, Davy became Certified Tes…
Pseudonymization and anonymization: what rules apply to our health data?
Pseudonymization and anonymization: what rules apply to our health data? 2142 zettabytes. This is th…
Your partner for Quantitative Susceptibility Mapping in Europe
Your partner for Quantitative Susceptibility Mapping in Europe QSM is an innovative patented techniq…
Ventio is proud to welcome Miguel Guevara in the QSM4SENIOR project!
Ventio is proud to welcome Miguel Guevara in the QSM4SENIOR project! Miguel joined the project-team …
Access control and authentification: threats and solutions
Access control and authentification: threats and solutions In terms of IT security, user’s man…
Quantum programming: a major technological challenge
Quantum programming: a major technological challenge Ventio is acquiring expertise in quantum progra…
Quantum attacks: Ventio protects sensitive environments thanks to post-quantum encryption
Protecting sensitive information and resisting quantum attacks: Ventio stays ahead of the curve and …
QSM4SENIOR: the gold standard for rusting brains
QSM4SENIOR: the gold standard for rusting brains Ventio and NeuroSpin are partners in a recently-sel…
Ventio becomes a member of the AFCDP
Ventio becomes a member of the French Association of Data Protection Officers (AFCDP) and strengthen…
Ventio synthesizes the new CNIL guidelines on health data warehouses
Deciphering the new CNIL guidelines on health data warehouses, Ventio gives you its synthesis! On No…
The security of cloud services
The security of cloud services In France, the national Information Systems Security agency (ANSSI) n…
Container technology: benefits and security
Container technology: benefits and security The boom in cloud computing has quickly led to the devel…
Healthcare data security: is your data sufficiently protected?
Healthcare data security: is your data sufficiently protected? The French supervisory authority (CNI…
Publications of the field
QSM Quantitative Susceptibility Mapping
Dr. Stephane ROCHE, PhD, Dr. Ludovic de ROCHEFORT, PhD; Novembre 2022 Definition: QSM (Quantitative …
QMRLucca 2022
QSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2…
QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectation…
Phenotypic and genetic associations of quantitative magnetic susceptibility
Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imag…
How does QSM perform in detecting this process?
Brain pathological changes during neurodegenerative diseases and their identification methods: How d…
FDA-clearance
510(k) Premarket Notification Device Classification Name system, nuclear magnetic resonance imaging …
QSM Patent
Accurate quantification of magnetic susceptibility in molecular mri Inventor: Yi Wang, Ludovic De Ro…
SENIOR cohort : imaging the aging brain
Imaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-…
Clinical Integration of Automated Processing for Brain QSM
Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Si…
Clinical Integration of QSM into Neurosurgical Practice
Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosur…
APP Ab38 Ab40 in FTD
Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audr…
Quantitative susceptibility map reconstruction
Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Val…
sAPP & Abeta in CSF
Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in…
Preanalytical guideline
Preanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Ro…
Biomarkers in CSF
Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications …
Autoantibody in CSF
Auto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrosp…
Quantitative MR susceptibility mapping
Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnet…
Clinical proteomics in CSF
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roc…
